Insider Trades53 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Sell | EYPT | Jay S. Duker | President and CEO | 8,059 | $14.72 | $1.1B | -30.40% | +41.49% | $118.6K | -45.65% | — | Trim |
| Jun 30, 2026 | Sell | EYPT | Ramiro Ribeiro | Chief Medical Officer | 9,750 | $11.63 | $1.1B | -30.40% | +41.49% | $113.4K | +0.00% | — | Trim |
| May 25, 2026 | Sell | EYPT | George Elston | Chief Financial Officer | 3,627 | $12.93 | $1.1B | -30.40% | +41.49% | $46.9K | -3.81% | — | Trim |
| Apr 17, 2026 | Sell | EYPT | Ramiro Ribeiro | Chief Medical Officer | 4,874 | $11.63 | $1.1B | -30.40% | +41.49% | $56.7K | +0.00% | — | Trim |
| Mar 16, 2026 | Buy | EYPT | Jay S. Duker | President and CEO | 1,500 | $13.15 | $1.1B | -30.40% | +41.49% | $19.7K | +1.51% | — | Trim |
| Mar 4, 2026 | Sell | EYPT | Ramiro Ribeiro | Chief Medical Officer | 4,876 | $13.07 | $1.1B | -30.40% | +41.49% | $63.7K | +0.00% | — | Trim |
| Mar 2, 2026 | Sell | EYPT | George Elston | Chief Financial Officer | 10,000 | $18.34 | $1.1B | -30.40% | +41.49% | $183.4K | +0.00% | — | Trim |
| Feb 17, 2026 | Sell | EYPT | Ramiro Ribeiro | Chief Medical Officer | 4,874 | $11.63 | $1.1B | -30.40% | +41.49% | $56.7K | +0.00% | — | Trim |
| Jan 6, 2026 | Sell | EYPT | George Elston | Chief Financial Officer | 4,487 | $16.86 | $1.1B | -30.40% | +41.49% | $75.7K | -4.66% | — | Trim |
| Jan 6, 2026 | Sell | EYPT | Jay S. Duker | President and CEO | 10,054 | $16.86 | $1.1B | -30.40% | +41.49% | $169.5K | -11.45% | — | Trim |
| Jan 5, 2026 | Sell | EYPT | Ramiro Ribeiro | Chief Medical Officer | 71,794 | $13.50 | $1.1B | -30.40% | +41.49% | $968.9K | -9.26% | — | Trim |
| Jan 3, 2026 | Sell | EYPT | Ramiro Ribeiro | Chief Medical Officer | 6,373 | $17.48 | $1.1B | -30.40% | +41.49% | $111.4K | -2.02% | — | Trim |
| Jan 3, 2026 | Sell | EYPT | George Elston | Chief Financial Officer | 10,727 | $17.46 | $1.1B | -30.40% | +41.49% | $187.3K | -2.64% | — | Trim |
| Jan 3, 2026 | Sell | EYPT | Jay S. Duker | President and CEO | 37,952 | $17.46 | $1.1B | -30.40% | +41.49% | $662.7K | -4.67% | — | Trim |
| Dec 19, 2025 | Sell | EYPT | George Elston | Chief Financial Officer | 10,000 | $17.43 | $1.1B | -30.40% | +41.49% | $174.3K | +0.00% | — | Trim |
| Nov 11, 2025 | Sell | EYPT | Ramiro Ribeiro | Chief Medical Officer | 2,722 | $11.61 | $1.1B | -30.40% | +41.49% | $31.6K | -100.00% | — | Trim |
| Sep 19, 2025 | Sell | EYPT | George Elston | Chief Financial Officer | 40,000 | $13.25 | $1.1B | -30.40% | +41.49% | $530.0K | +0.00% | — | Trim |
| Jul 10, 2025 | Sell | EYPT | Jay S. Duker | President and CEO | 7,688 | $11.06 | $1.1B | -30.40% | +41.49% | $85.0K | -22.40% | — | Trim |
| May 25, 2025 | Sell | EYPT | George Elston | Chief Financial Officer | 2,202 | $5.68 | $1.1B | -30.40% | +41.49% | $12.5K | -2.43% | — | Trim |
| Feb 9, 2025 | Sell | EYPT | Jay S. Duker | President and CEO | 2,055 | $6.50 | $1.1B | -30.40% | +41.49% | $13.3K | -2.58% | — | Trim |
| Jan 5, 2025 | Sell | EYPT | George Elston | Chief Financial Officer | 10,075 | $8.46 | $1.1B | -30.40% | +41.49% | $85.2K | -2.71% | — | Trim |
| Jan 5, 2025 | Sell | EYPT | Jay S. Duker | President and CEO | 16,115 | $8.42 | $1.1B | -30.40% | +41.49% | $135.7K | -1.86% | — | Trim |
| Jul 10, 2024 | Sell | EYPT | Jay S. Duker | President and CEO | 8,059 | $8.69 | $1.1B | -30.40% | +41.49% | $70.0K | -10.15% | — | Trim |
| May 25, 2024 | Sell | EYPT | George Elston | Chief Financial Officer | 3,627 | $11.16 | $1.1B | -30.40% | +41.49% | $40.5K | -5.49% | — | Trim |
| Mar 30, 2024 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 25,546 | $20.67 | $1.1B | -30.40% | +41.49% | $528.0K | -10.47% | — | Trim |
| Feb 27, 2024 | Sell | EYPT | Jay S. Duker | President and CEO | 5,000 | $28.67 | $1.1B | -30.40% | +41.49% | $143.3K | +0.00% | — | Trim |
| Feb 20, 2024 | Sell | EYPT | Jay S. Duker | President and CEO | 40,000 | $27.70 | $1.1B | -30.40% | +41.49% | $1.1M | +0.00% | — | Trim |
| Feb 9, 2024 | Sell | EYPT | George Elston | Chief Financial Officer | 3,192 | $28.80 | $1.1B | -30.40% | +41.49% | $91.9K | -3.27% | — | Trim |
| Feb 9, 2024 | Sell | EYPT | Jay S. Duker | President and CEO | 3,533 | $28.80 | $1.1B | -30.40% | +41.49% | $101.8K | -3.05% | — | Trim |
| Feb 9, 2024 | Sell | EYPT | David Scott Jones | SVP & Chief Commercial Officer | 3,656 | $28.80 | $1.1B | -30.40% | +41.49% | $105.3K | -3.65% | — | Trim |
| Feb 9, 2024 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 5,083 | $28.80 | $1.1B | -30.40% | +41.49% | $146.4K | -5.19% | — | Trim |
| Feb 9, 2024 | Sell | EYPT | Nancy Lurker | Executive Vice Chair | 164,305 | $2.62 | $1.1B | -30.40% | +41.49% | $430.4K | -1.36% | — | Trim |
| Feb 2, 2024 | Sell | EYPT | David Scott Jones | SVP & Chief Commercial Officer | 418 | $19.98 | $1.1B | -30.40% | +41.49% | $8.4K | +0.00% | — | Trim |
| Jan 26, 2024 | Sell | EYPT | David Scott Jones | SVP & Chief Commercial Officer | 52,034 | $16.10 | $1.1B | -30.40% | +41.49% | $837.8K | +0.00% | — | Trim |
| Jan 26, 2024 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 98,650 | $19.36 | $1.1B | -30.40% | +41.49% | $1.9M | +0.00% | — | Trim |
| Jan 25, 2024 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 1,200 | $19.01 | $1.1B | -30.40% | +41.49% | $22.8K | +0.00% | — | Trim |
| Jan 24, 2024 | Sell | EYPT | David Scott Jones | SVP & Chief Commercial Officer | 23,800 | $16.52 | $1.1B | -30.40% | +41.49% | $393.3K | +0.00% | — | Trim |
| Jan 23, 2024 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 32,772 | $19.02 | $1.1B | -30.40% | +41.49% | $623.2K | +0.00% | — | Trim |
| Jan 23, 2024 | Sell | EYPT | Nancy Lurker | Executive Vice Chair | 35,000 | $24.98 | $1.1B | -30.40% | +41.49% | $874.2K | -4.45% | — | Trim |
| Jan 22, 2024 | Sell | EYPT | David Scott Jones | SVP & Chief Commercial Officer | 70,132 | $16.47 | $1.1B | -30.40% | +41.49% | $1.2M | +0.00% | — | Trim |
| Jan 8, 2024 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 45,826 | $12.19 | $1.1B | -30.40% | +41.49% | $558.8K | +0.00% | — | Trim |
| Jan 6, 2024 | Sell | EYPT | David Scott Jones | SVP & Chief Commercial Officer | 4,147 | $20.40 | $1.1B | -30.40% | +41.49% | $84.6K | -3.06% | — | Trim |
| Jan 6, 2024 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 4,487 | $20.40 | $1.1B | -30.40% | +41.49% | $91.5K | -3.33% | — | Trim |
| Jan 6, 2024 | Sell | EYPT | George Elston | Chief Financial Officer | 4,911 | $20.40 | $1.1B | -30.40% | +41.49% | $100.2K | -2.39% | — | Trim |
| Jan 6, 2024 | Sell | EYPT | Michael Craig Pine | Chief Corp Dev.&Strat. Officer | 5,966 | $20.40 | $1.1B | -30.40% | +41.49% | $121.7K | -5.27% | — | Trim |
| Jan 6, 2024 | Sell | EYPT | Jay S. Duker | President and CEO | 6,528 | $20.40 | $1.1B | -30.40% | +41.49% | $133.2K | -1.81% | — | Trim |
| Jan 6, 2024 | Sell | EYPT | Nancy Lurker | Executive Vice Chair | 23,043 | $20.40 | $1.1B | -30.40% | +41.49% | $470.1K | -5.02% | — | Trim |
| Dec 28, 2023 | Sell | EYPT | Nancy Lurker | Executive Vice Chair | 104,416 | $23.56 | $1.1B | -30.40% | +41.49% | $2.5M | +0.00% | — | Trim |
| Dec 13, 2023 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 2,916 | $15.06 | $1.1B | -30.40% | +41.49% | $43.9K | +0.00% | — | Trim |
| Dec 4, 2023 | Sell | EYPT | Nancy Lurker | Executive Vice Chair | 20,000 | $20.76 | $1.1B | -30.40% | +41.49% | $415.2K | -10.50% | — | Trim |
| Dec 4, 2023 | Sell | EYPT | Dario A. Paggiarino | Chief Medical Officer | 61,250 | $16.07 | $1.1B | -30.40% | +41.49% | $984.0K | +0.00% | — | Trim |
| Dec 4, 2023 | Sell | EYPT | Michael Craig Pine | Chief Corp Dev.&Strat. Officer | 90,000 | $17.31 | $1.1B | -30.40% | +41.49% | $1.6M | +0.00% | — | Trim |
| Dec 4, 2023 | Sell | EYPT | Michael Craig Pine | Chief Corp Dev.&Strat. Officer | 91,000 | $17.35 | $1.1B | -30.40% | +41.49% | $1.6M | -0.86% | — | Trim |